| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
139.000 |
Evidence |
O
|
| TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
137.000 |
Evidence |
O
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
RELB |
RELB: Transcription factor RelB |
137.000 |
Evidence |
O
|
| CDC37 |
CDC37: Hsp90 co-chaperone Cdc37 |
HSP90AA1 |
Hsp89-alpha-delta-N |
136.000 |
Evidence |
O
|
| FADD |
FADD, MORT1: Protein FADD |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
135.000 |
Evidence |
O
|
| VIL2 |
IPI00479359 |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
135.000 |
Evidence |
O
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
135.000 |
Evidence |
O
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
BTC |
BTC: Probetacellulin precursor [Contains: Betacellulin |
135.000 |
Evidence |
O
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
132.000 |
Evidence |
O
|
| ATP5B |
ATP5B, ATPMB, ATPSB: ATP synthase subunit beta, mitochondrial precursor |
ATP5A1 |
ATP5A1, ATP5A, ATP5AL2, ATPM: ATP synthase subunit alpha, mitochondrial precurso |
131.000 |
Evidence |
O
|
| EIF2B2 |
EIF2B2, EIF2BB: Translation initiation factor eIF-2B subunit beta |
EIF2B1 |
EIF2B1, EIF2BA: Translation initiation factor eIF-2B subunit alpha |
131.000 |
Evidence |
O
|
| CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYGC |
CRYGC, CRYG3: Gamma-crystallin C |
130.000 |
Evidence |
O
|
| TPD52L1 |
TPD52L1: Tumor protein D53 |
TPD52 |
TPD52: Tumor protein D52 |
128.000 |
Evidence |
O
|
| F8 |
F8, F8C: Coagulation factor VIII precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
128.000 |
Evidence |
O
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
128.000 |
Evidence |
O
|
| CHEK1 |
CHEK1, CHK1: Serine/threonine-protein kinase Chk1 |
LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
123.000 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
122.000 |
Evidence |
O
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
121.000 |
Evidence |
O
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
119.000 |
Evidence |
O
|
| LNK |
SH2B3, LNK: SH2B adapter protein 3 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
119.000 |
Evidence |
O
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
119.000 |
Evidence |
O
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
114.000 |
Evidence |
O
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
CCNB1 |
Cyclin B1 |
114.000 |
Evidence |
O
|
| RAB5A |
RAB5A, RAB5: Ras-related protein Rab-5A |
GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
112.000 |
Evidence |
O
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB8B |
RAB8B: Ras-related protein Rab-8B |
112.000 |
Evidence |
O
|
